Premenstrual Disorders: A Primer and Research Agenda for Psychologists

Overview

Journal Clin Psychol

Specialty Psychology

Date 2020 May 5

PMID 32362679

Citations 17

Authors

Tory Eisenlohr-Moul

Affiliations

Soon will be listed here.

Citing Articles

Hormonal Contraceptive Use and Affective Disorders: An Updated Review.

Mengelkoch S, Afshar K, Slavich G Open Access J Contracept. 2025; 16:1-29.

PMID: 39959454 PMC: 11829607. DOI: 10.2147/OAJC.S431365.

A call to integrate menstrual cycle influences into just-in-time adaptive interventions for suicide prevention.

Tauseef H, Coppersmith D, Reid-Russell A, Nagpal A, Ross J, Nock M Front Psychiatry. 2024; 15:1434499.

PMID: 39703456 PMC: 11655188. DOI: 10.3389/fpsyt.2024.1434499.

Menstrual cycle related depressive symptoms and their diurnal fluctuations - an ambulatory assessment study.

Klusmann H, Brose A, Schulze L, Engel S, Laufer S, Bucklein E BMC Womens Health. 2024; 24(1):611.

PMID: 39551735 PMC: 11572536. DOI: 10.1186/s12905-024-03438-9.

The experiences and psychological impact of living with premenstrual disorders: a systematic review and thematic synthesis.

Brown D, Smith D, Osborn E, Wittkowski A Front Psychiatry. 2024; 15:1440690.

PMID: 39286397 PMC: 11402655. DOI: 10.3389/fpsyt.2024.1440690.

Is trait rumination associated with affective reactivity to the menstrual cycle? A prospective analysis.

Tauseef H, Schmalenberger K, Barone J, Ross J, Peters J, Girdler S Psychol Med. 2024; 54(8):1824-1834.

PMID: 38284220 PMC: 11132929. DOI: 10.1017/S0033291723003793.

References

Martel M, Eisenlohr-Moul T, Roberts B . Interactive effects of ovarian steroid hormones on alcohol use and binge drinking across the menstrual cycle. J Abnorm Psychol. 2017; 126(8):1104-1113. PMC: 5726306. DOI: 10.1037/abn0000304. View

Linehan M, Comtois K, Murray A, Brown M, Gallop R, Heard H . Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006; 63(7):757-66. DOI: 10.1001/archpsyc.63.7.757. View

Eisenlohr-Moul T, DeWall C, Girdler S, Segerstrom S . Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone. Biol Psychol. 2015; 109:37-52. PMC: 4516641. DOI: 10.1016/j.biopsycho.2015.03.016. View

Eisenlohr-Moul T, Schmalenberger K, Owens S, Peters J, Dawson D, Girdler S . Perimenstrual exacerbation of symptoms in borderline personality disorder: evidence from multilevel models and the Carolina Premenstrual Assessment Scoring System. Psychol Med. 2018; 48(12):2085-2095. PMC: 6436806. DOI: 10.1017/S0033291718001253. View

Pineles S, Nillni Y, Pinna G, Irvine J, Webb A, Arditte Hall K . PTSD in women is associated with a block in conversion of progesterone to the GABAergic neurosteroids allopregnanolone and pregnanolone measured in plasma. Psychoneuroendocrinology. 2018; 93:133-141. DOI: 10.1016/j.psyneuen.2018.04.024. View

Steinberg E, Cardoso G, Martinez P, Rubinow D, Schmidt P . Rapid response to fluoxetine in women with premenstrual dysphoric disorder. Depress Anxiety. 2012; 29(6):531-40. PMC: 3442940. DOI: 10.1002/da.21959. View

Owens S, Eisenlohr-Moul T . Suicide Risk and the Menstrual Cycle: a Review of Candidate RDoC Mechanisms. Curr Psychiatry Rep. 2018; 20(11):106. PMC: 6844188. DOI: 10.1007/s11920-018-0962-3. View

Hantsoo L, Epperson C . Premenstrual Dysphoric Disorder: Epidemiology and Treatment. Curr Psychiatry Rep. 2015; 17(11):87. PMC: 4890701. DOI: 10.1007/s11920-015-0628-3. View

Kleinstauber M, Witthoft M, Hiller W . Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis. J Clin Psychol Med Settings. 2012; 19(3):308-19. DOI: 10.1007/s10880-012-9299-y. View

10.

Peters W, Freeman M, Kim S, Cohen L, Joffe H . Treatment of Premenstrual Breakthrough of Depression With Adjunctive Oral Contraceptive Pills Compared With Placebo. J Clin Psychopharmacol. 2017; 37(5):609-614. DOI: 10.1097/JCP.0000000000000761. View

11.

Craner J, Sigmon S, Martinson A . Self-focused attention in response to laboratory stressors among women with premenstrual disorders. Arch Womens Ment Health. 2015; 18(4):595-606. DOI: 10.1007/s00737-015-0505-4. View

12.

Steiner M, Pearlstein T, Cohen L, Endicott J, Kornstein S, Roberts C . Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt). 2006; 15(1):57-69. DOI: 10.1089/jwh.2006.15.57. View

13.

Nock M, Borges G, Bromet E, Cha C, Kessler R, Lee S . Suicide and suicidal behavior. Epidemiol Rev. 2008; 30:133-54. PMC: 2576496. DOI: 10.1093/epirev/mxn002. View

14.

Gollenberg A, Hediger M, Mumford S, Whitcomb B, Hovey K, Wactawski-Wende J . Perceived stress and severity of perimenstrual symptoms: the BioCycle Study. J Womens Health (Larchmt). 2010; 19(5):959-67. PMC: 2875955. DOI: 10.1089/jwh.2009.1717. View

15.

Schmidt P, Martinez P, Nieman L, Koziol D, Thompson K, Schenkel L . Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels. Am J Psychiatry. 2017; 174(10):980-989. PMC: 5624833. DOI: 10.1176/appi.ajp.2017.16101113. View

16.

Edler C, Lipson S, Keel P . Ovarian hormones and binge eating in bulimia nervosa. Psychol Med. 2006; 37(1):131-41. DOI: 10.1017/S0033291706008956. View

17.

Cronje W, Vashisht A, Studd J . Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod. 2004; 19(9):2152-5. DOI: 10.1093/humrep/deh354. View

18.

Agis-Balboa R, Guidotti A, Pinna G . 5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients. Psychopharmacology (Berl). 2014; 231(17):3569-80. PMC: 6223254. DOI: 10.1007/s00213-014-3567-5. View

19.

Gehlert S, Song I, Chang C, Hartlage S . The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychol Med. 2008; 39(1):129-36. PMC: 2752820. DOI: 10.1017/S003329170800322X. View

20.

Freeman E, Halbreich U, Grubb G, Rapkin A, Skouby S, Smith L . An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception. 2011; 85(5):437-45. DOI: 10.1016/j.contraception.2011.09.010. View